United Therapeutics to build $500M manufacturing facility in RTP
Published June 30, 2023
“A multibillion-dollar company is growing its footprint in Research Triangle Park with plans for a $500 million manufacturing facility.
United Therapeutics (Nasdaq: UTHR) is building the facility to expand its capacity to produce a drug-device combination product that received approval by the U.S. Food and Drug Administration last year. The product, Tyvaso DPI, is a central part of the company’s growth strategy as it aims to double its revenue in the coming years.”
Read more at the Triangle Business Journal (subscribers only)
